| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |